
PMCB
NSCPharmaCyte Biotech Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Friday 18th July 2025
1.02
-0.10 (-8.93%)
Prev Close:1.12
Open:1.1
Bid:1.0
Ask:1.14
52 Week Range
1.002.42
Volume:11,500
Mkt Cap:8 M
62
MarketXLS Rank ®
Buy
Price Target
$1.17
+14.7%
Financial Statements
PMCB - Income Statement (Annual)
Apr-24 | Apr-23 | Apr-22 | Apr-21 | Apr-20 | Apr-19 | Apr-18 | Apr-17 | Apr-16 | Apr-14 | |
---|---|---|---|---|---|---|---|---|---|---|
Accretion On Preferred Stock | 15 M | |||||||||
Accrued Preferred Stock Dividends | 3 M | |||||||||
Acquisition Expense | 406812.0 | |||||||||
Commission Expenses | 768000.0 | |||||||||
Depreciation And Amortization | 406812.0 | |||||||||
Development Expense | 65500.0 | |||||||||
Earnings From Equity Interest | 5876.0 | |||||||||
Earnings From Equity Interest Net Of Tax | 5876.0 | |||||||||
Fees | -45000.0 | |||||||||
Gain On Sale Of PPE | -2 M | |||||||||
General And Administrative Expense | 5 M | 5 M | 2 M | 1 M | 2 M | 2 M | 2 M | 1 M | 3 M | 3 M |
Interest Expense Non Operating | 509.0 | 3046.0 | 453.0 | 1539.0 | 1191.0 | 19963.0 | ||||
Interest Expense Operating | 45000.0 | |||||||||
Marketing Expense | 326540.0 | 65500.0 | ||||||||
Misc Other Special Charges | 191145.0 | 202002.0 | -4283.0 | 74791.0 | -40.0 | 33401.0 | 152588.0 | -1539.0 | 10540.0 | -10 M |
Net Income (loss) | 333763.0 | -4 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -27 M |
Net Income Common Stockholders | -17 M | -4 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -27 M |
Net Income Continuous Operations | 333763.0 | -4 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -27 M |
Net Non Operating Interest Income Expense | 3 M | 2 M | 157136.0 | -3046.0 | -453.0 | -1539.0 | -1191.0 | -19963.0 | ||
Normalized Income | -3 M | -5 M | -4 M | |||||||
Operating Income | -9 M | -6 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -18 M |
Operating Income Before Depreciation (EBITDA) | 333763.0 | -5 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -29 M |
Operating Expense | 9 M | 6 M | 4 M | 4 M | 4 M | -4 M | -7 M | -4 M | -6 M | -19 M |
Other Gand A | 5 M | 5 M | 2 M | 1 M | 2 M | 2 M | 2 M | 1 M | 3 M | 3 M |
Other Impairment Of Capital Assets | 2 M | |||||||||
Other Operating Expenses | 29546.0 | 23420.0 | 19341.0 | 20429.0 | 30964.0 | -4 M | -6 M | -19 M | ||
Other Write Down | 326540.0 | 768000.0 | ||||||||
Otherunder Preferred Stock Dividend | 18 M | |||||||||
Preferred Stock Dividends | 18 M | |||||||||
Rent And Landing Fees | 1 M | 2 M | 744796.0 | 2 M | 2 M | |||||
Research Expense | 407431.0 | 468536.0 | 690937.0 | 916249.0 | 301221.0 | 460052.0 | 2 M | 1 M | 1 M | 323500.0 |
Salaries And Wages | 1 M | 1 M | 2 M | 1 M | 2 M | 2 M | 2 M | 2 M | 2 M | 14 M |
Selling And Marketing Expense | 326540.0 | 65500.0 | 872200.0 | |||||||
Selling Expense | 872200.0 | |||||||||
Total Income Available For Interest Expense (EBIT) | 333763.0 | -5 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -29 M |
Total Expenses | 9 M | 6 M | 4 M | 4 M | 4 M | -4 M | -7 M | 4 M | -6 M | -19 M |
Amord | 406812.0 | |||||||||
Avgshs | 10 M | 19 M | 16 M | 1 M | 903811.0 | 733402.0 | 645761.0 | 563539.0 | 501602.0 | 388813.0 |
Avgshsdt | 10 M | 19 M | 16 M | 1 M | 903811.0 | 733402.0 | 645761.0 | 563539.0 | 501602.0 | 388813.0 |
Basiceps | -1.8 | -0.22 | -0.27 | -2.45 | -75.0 | |||||
Basicepscont | -1.8 | -0.22 | -0.27 | -2.45 | ||||||
Depamor | 406812.0 | |||||||||
Dileps | -1.8 | -0.22 | -0.27 | -2.45 | -15.0 | -15.0 | -15.0 | |||
Dilepscont | -1.8 | -0.22 | -0.27 | |||||||
Intinc | 3 M | 2 M | 157645.0 | 1090.0 | ||||||
Netincdisc | 333763.0 | -4 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -27 M |
Othincexp | 3 M | -202002.0 | -4283.0 | -74791.0 | 40.0 | -33401.0 | -152588.0 | 1539.0 | -10540.0 | 11 M |
Pretaxinc | -7 M | -4 M | -4 M | -4 M | -4 M | -4 M | -7 M | -4 M | -6 M | -29 M |
Resdev | 407431.0 | 468536.0 | 690937.0 | 916249.0 | 301221.0 | 460052.0 | 2 M | 1 M | 1 M | 323500.0 |
Sga | 5 M | 5 M | 2 M | 1 M | 2 M | 2 M | 3 M | 1 M | 3 M | 4 M |
Shsout | 8 M | 9 M | 21 M | 2 M | 2 M | 885447.0 | 694025.0 | 648778.0 | 565369.0 | 472837.0 |
Taxprov | -906359.0 | -890224.0 | -745760.0 | -803646.0 | -6454.0 | -887749.0 | -195211.0 | -2 M |